Natural product-derived combination therapy for blood-stage Plasmodium infection: A therapeutic mix encompassing Artemisinin, Chloroquine, and Amodiaquine [ACA] decreases the expression of CTLA-4, PD-L1 and LAG-3, promotes CD4+ T-cell function, increases secretion of protective antibodies, promotes and clear blood-stage malaria via up regulation of its target gene, 5/October/2017, 12.50 am
https://genomediscovery.org/wp-content/uploads/2017/10/ACA-acts-as-an-antiviral-agent-against-blood-stage-malaria-through-down-regulation-of-CTLA-4-PD-1-PD-L1-and-LAG-32.jpg3_.jpg
960
720
Dr Boomi's Genom-2-Discovery Center
https://genomediscovery.org/wp-content/uploads/2017/10/ACA-acts-as-an-antiviral-agent-against-blood-stage-malaria-through-down-regulation-of-CTLA-4-PD-1-PD-L1-and-LAG-32.jpg3_.jpg
Introduction: What they say A study from the Department of Microbiology and Immunology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA shows that “Regulatory T cells impede…
read more